go back

Melanoma Versus Benign Mole Gene Test

Tennessee rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $1,950 · 10th–90th $1,479$6,9180%10%10th90th$1,950Professionalmedian $1,549 · 10th–90th $1,175$1,9500%20%40%10th90th$1,549$500.0$1.0K$2.0K$5.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,479.11
Median
$2,137.96
Typical High
$6,918.31
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,479.11
Median
$1,548.82
Typical High
$1,737.80
BCBS
Setting
Professional
Modifier
Global
Typical Low
$1,023.29
Median
$1,949.84
Typical High
$1,949.84
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,318.26
Median
$2,238.72
Typical High
$6,918.31
Cigna
Setting
Professional
Modifier
Global
Typical Low
$1,949.84
Median
$1,949.84
Typical High
$1,949.84
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$9,332.54
Median
$9,332.54
Typical High
$9,332.54
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$9,772.37
Median
$14,791.08
Typical High
$14,791.08
United
Setting
Facility
Modifier
Global
Typical Low
$812.83
Median
$1,949.84
Typical High
$1,949.84
United
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$1,174.90
Typical High
$1,949.84